The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's By Dennis Thompson HealthDay Reporter THURSDAY, Sept. 19, 2024 (HealthDay News) -- A specific class of diabetes drug appears to lower ...

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer's disease or Parkinson's disease, and a 30% reduced risk of ...

A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer’s disease or Parkinson’s disease, and a 30% reduced ...